HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

NVST

Envista Holdings Corporation (NYSE)

Healthcare — Medical Instruments & Supplies

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

None 13 analysts
$27.17
+$0.82 (+3.11%)
Target: $29.69 (9.3%)
Sign in to add NVST to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$4.42B
P/E Ratio (TTM)66.27
Forward P/E17.28
EPS (TTM)$0.41
Dividend Yield-
Profit Margin2.41%
Revenue Growth14.40%
ROE2.21%
Debt/Equity51.61
Recommendation None
Analyst Target$29.69
Analysts13
Indexes NYSE

Technical Indicators

RSI (14)77.0
Beta0.89
SMA 20-
SMA 40-
52-Week High$30.42
52-Week Low$18.77
50-Day Avg$24.90
200-Day Avg$23.67
Avg Volume$3.05M
Volume$2.70M

Performance Analysis

NEUTRAL

NVST presents a mixed picture with both positive and negative indicators.

+ Showing strength at 72% of its 52-week range.
- RSI at 77.0 indicates overbought conditions — a pullback may be due.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
- P/E of 66.3 is elevated — the market expects high growth or it may be overvalued.
~ Modest revenue growth of 14.4% year-over-year.
~ Wall Street consensus is "none" from 13 analysts.
+ Average analyst target of $29.69 implies 9.3% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:23 UTC

Back to Screener Export Report